Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Banco Santander $3.5 billion cash tender offers
We advised Banco Santander on its tender offers for fixed-rate notes
Arcos Dorados renewal of long-term master franchise agreement with McDonald’s
We advised Arcos Dorados on the transaction
SMFG $3.2 billion senior notes offering
We advised SMFG on its SEC-registered offering of TLAC notes
BBVA $1 billion preferred securities offering
We advised BBVA on its offering of contingent convertible perpetual preferred securities
Toyota Motor Credit $2.6 billion notes offering
We advised Toyota Motor Credit on the SEC-registered notes offering
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
The Baldwin Group $935 million credit facilities financing
We advised the borrower on the refinancing and amendment
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition